Adapthealth Corp (OQ:AHCO)
Business Focus: Medical Equipment, Supplies & Distribution
| Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 220 W Germantown Pike Ste 250 PLYMOUTH MEETING PA 19462 |
| Tel: | N/A |
| Website: | https://adapthealth.com/investor-relations |
| IR: | See website |
| Key People | ||
| Richard A. Barasch Chairman of the Board, Interim Chief Executive Officer | Joshua Parnes President, Director | Suzanne M. Foster Chief Executive Officer |
| Jason A. Clemens Chief Financial Officer | Shaw Rietkerk Chief Operating Officer | Albert Prast Chief Technology Officer | Christie Archbold Chief Accounting Officer |
| Business Overview |
| Adapthealth Corp. provides patient-centered, healthcare-at-home solutions, including home medical equipment (HME), medical supplies and related services. The Company is primarily focused on providing sleep therapy equipment, supplies and related services, including CPAP and bi PAP services to individuals suffering from obstructive sleep apnea (OSA); medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors (CGM) and insulin pumps; home medical equipment to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The Company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. It serves patients annually in all 50 states through its network of approximately 680 locations in 47 states. |
| Financial Overview |
| For the fiscal year ended 31 December 2023, Adapthealth Corp revenues increased 8% to $3.2B. Net loss applicable to common stockholders totaled $678.9M vs. income of $63.4M. Revenues reflect Insurance segment increase of 7% to $1.93B, Government segment increase of 9% to $852.8M. Net loss reflects General and administrative expenses increase of 19% to $144.6M (expense), Other loss (income). |
| Employees: | 10,700 as of Dec 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $3,403M as of Dec 31, 2023 |
| Annual revenue (TTM): | $3,200M as of Dec 31, 2023 |
| EBITDA (TTM): | $621.63M as of Dec 31, 2023 |
| Net annual income (TTM): | -$678.90M as of Dec 31, 2023 |
| Free cash flow (TTM): | $143.20M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | $2,103M as of Dec 31, 2023 |
| Shares outstanding: | 132,907,103 as of Feb 23, 2024 |
| Index Membership: | S&P 600 Small Cap |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.